CorMedix Inc. (CRMD) is a publicly traded company in the Unknown sector. Across all available filings, 35 corporate insiders have executed 346 transactions totaling $10.4M, demonstrating a bearish sentiment with -$2.8M in net insider flow. The most recent transaction on Feb 4, 2026 involved a transaction of 77,156 shares valued at $0.
No significant insider buying has been recorded for CRMD in the recent period.
No significant insider selling has been recorded for CRMD in the recent period.
Based on recent SEC filings, insider sentiment for CRMD is bearish with an Insider Alignment Score of 36/100 and a net flow of -$2.8M. Insiders are reducing their positions, though this can be driven by factors unrelated to company outlook.
Insider trading at CorMedix Inc. (CRMD) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 35 insiders are actively trading CRMD stock, having executed 346 transactions in the past 90 days. The most active insider is Steven W. Lefkowitz (Executive), who has made 40 transactions totaling $351.6M.
Get notified when executives and directors at CRMD file new Form 4 transactions
Date | Insider | Title | Type | Shares | Price | Value | Flags |
|---|---|---|---|---|---|---|---|
| Feb 4, 2026 | Todisco Joseph | Executive | Award | 77,156 | $N/A | $0 | |
| Feb 4, 2026 | Hurlburt Elizabeth | Chief Operating Officer | Award | 36,006 | $N/A | $0 | C-Suite |
| Feb 4, 2026 | Beth Zelnick Kaufman | Chief Legal Officer | Award | 36,006 | $N/A | $0 | |
| Jan 26, 2026 | A. Stewart Robert | Executive | Award | 30,453 | $N/A | $0 | |
| Jan 26, 2026 | Scott Duncan Gregory | Executive | Award | 30,453 | $N/A | $0 | |
| Jan 26, 2026 | W. Dunton Alan | Executive | Award | 30,453 | $N/A | $0 | |
| Jan 26, 2026 | W. Lefkowitz Steven | Executive | Award | 30,453 | $N/A | $0 | |
| Jan 26, 2026 | Dillione Janet | Executive | Award | 30,453 | $N/A | $0 | |
| Jan 26, 2026 | Kaplan Myron | Executive | Award | 30,453 | $N/A | $0 | |
| Jan 23, 2026 | Todisco Joseph | Executive | Payment | 27,306 | $7.27 | $198.5K | |
| Jan 23, 2026 | Todisco Joseph | Executive | Award | 225,900 | $N/A | $0 | |
| Jan 23, 2026 | Hurlburt Elizabeth | Chief Operating Officer | Payment | 10,778 | $7.27 | $78.4K | C-Suite |
| Jan 23, 2026 | Hurlburt Elizabeth | Chief Operating Officer | Award | 93,010 | $N/A | $0 | C-Suite |
| Jan 23, 2026 | Beth Zelnick Kaufman | Chief Legal Officer | Payment | 8,803 | $7.27 | $64.0K | |
| Jan 23, 2026 | Beth Zelnick Kaufman | Chief Legal Officer | Award | 72,820 | $N/A | $0 |
| TYPE | COUNT | VALUE | % |
|---|---|---|---|
Payment(F) | 24 | $354.2M | 95.9% |
Sale(S) | 55 | $6.6M | 1.8% |
Exercise(M) | 53 | $4.0M | 1.1% |
Purchase(P) | 139 | $3.8M | 1.0% |
Exercise (Options)(X) | 10 | $368.2K | 0.1% |
Conversion(C) | 10 | $210.0K | 0.1% |
Award(A) | 51 | $155.1K | 0.0% |
Gift(G) | 4 | $0 | 0.0% |
Insider selling pressure at CorMedix Inc. has increased, with 35 insiders executing 346 transactions across all time. Total sales of $6.6M significantly outpace purchases of $3.8M, resulting in a net outflow of $2.8M. This selling activity appears largely discretionary, which may warrant closer attention from investors.